Summary.-A rat mammary carcinoma induced by [7][8][9][10][11][12] (Miller, 1976a) and in vivo (Miller, 1976b,c; Buchan et al., 1976) . The Tumour -steroid metaboli8M.-A portion of each tumour (0-5 g) was finely sliced in KrebsRinger phosphate buffer, pH 7-4 (5 ml). An
(DMBA) have been shown to metabolize testosterone, primarily by 5cx reduction, an activity which may be influenced by hormones both in vitro (Miller, 1976a) and in vivo (Miller, 1976b,c; Buchan et al., 1976) . The Tumour -steroid metaboli8M.-A portion of each tumour (0-5 g) was finely sliced in KrebsRinger phosphate buffer, pH 7-4 (5 ml). An NADPH-generating system and 20 .Xi [7(x3H] testosterone was added and the systems incubated for I h at 37T in an atmnosphere of 02. Reaction was halted by addition of methanol (30 ml) and the incubations stored at -10°C until the metabolites were characterized by the methods previously described (Miller et al., 1974) . Metabolism and conversion of testosterone were determined by measuring radioactive label in the appropriate metabolites. Estimation of 5a reduction was obtained by combining the production of 5a-dihydrotesterone with that of 5o-androstanediol.
DNA estimation. Tumour DNA content was determined by a modification of the method of Burton (1956) .
RESULTS

Tumour growth
The effect of endocrine manipulation was not studied in the primary DMBAinduced tumour Table II. _ x s * 1 7 § _ * X * X X _ _ X _ X _ s s U U l Tables I and II . In all tumours, 5oreduc-tion of testosterone to 5aodihydrotesterone and 5afandrostanediol accounted for most of the metabolism. In tumours from endocrine-unmanipulated animals (Table I) transformation of testosterone was roughly similar in TG 5/1 and TG 5/2 tumours. However, metabolism was higher in tumours from the TG 5/3 generation, and a further raised level of metabolism was noted in TG 5/4 and TG 5/7 tumours. This change in metabolism with successive transplantation was accounted for by a parallel increase in 5ct reduction of testosterone, this being particularly evident in the conversion to 5oaandrostanediol. Results in tumours from animals after endocrine procedures are shown in Table II Horn et al., 1976) . Whilst later generations of transplantable tumours do not regress after oophorectomy, they may retain some degree of sensitivity to hormones (Hilf, 1972) . In the present study the growth of TG 5/4 and TG 5/7 tumours, though not influenced by ovarian ablation, appears to be stimulated by administration of oestrogen to oophorectomized animals. Although oestrogen-receptor activity was detectable in cytosols from TG 5/7 tumours (mean receptor level 3-4 fmol/mg protein, Kq 0 45 x 10-10M) the levels were much lower than in DMBA-induced hormone-dependent rat mammary tumours (Hawkins et al., 1978) .
In addition to determining the effects of tranplantation on tumour endocrine response, successive generations of tumours have been examined for their ability to metabolize testosterone in vitro. In all generations of tumours studied, 5a-reduced products were the major metabolites of testosterone. However, with successive transplantation there was an increase in tumour metabolism and 5aS reduction of testosterone, such that there was a doubling of 5az reduction between TG 5/1 and TG 5/7 tumours taken from endocrine-unmanipulated animals.
Scandrostanediol (3oa 178) appeared to be the metabolite most consistently affected and it may be that the effects of 5ox reduction are secondary to those on 3oihydroxysteroid dehydrogenase. However, under the incubation conditions used, 5acandrostanediol was the single greatest Sc reduced product identified, and effects on 5af reduction are most likely to be evident in this metabolite. A similar but smaller rise in 5a reduction with increasing number of passages was evident in endocrine-treated animals. Endocrine manipulation itself has been shown to influence 5oa reduction in these tumours: oophorectomy increases the activity and oestrogen administration to oophorectomized animals decreases the 5a, reduction (Miller et al., 1979 (Yamaguchi et al., 1974) . Although no significant difference in steroid metabolism was detected between hormone-dependent and independent DMBA-induced rat mammary tumours (King et al., 1965) endocrine-treated animals were used and in the present study effects in such animals were more difficult to detect than in unmanipulated animals. Furthermore the levels of tumour 5ct reduction were at least 10-fold less (King et al., 1964) than those reported in the system used in the present study. It is possible that the apparent relationship detected in this study between hormone dependence and steroid metabolism is only causal and that some other feature of transplantation has caused the observed increase in testosterone metabolism.
Difference in tumour growth rate is unlikely, as all tumours were actively growing at the time of study. A simple increase in tumour cellularity is also unlikely, because there was no evidence for an increase in tumour DNA content or histology with transplantation. However, a general increase in cellular metabolism cannot be excluded, and no information is available on the metabolism of other steroid precursors.
Until the specificity of the changes in steroid metabolism is further defined, the physiological relevance of these effects 329 must remain in doubt. However, to the author's knowledge this is the first documented observation that successive transplantation may affect tumour steroid metabolism. That a change in tumour hormone dependence occurs concurrently and the steroid conversion involved is one which may be hormonally influenced (Miller, 1976a,b,c; Buchan et al., 1976) gives added interest to the findings.
